Hcw biologics' founder and ceo to address opportunities and challenges in biomanufacturing for cell and gene therapies during j.p. morgan week in san francisco on january 15, 2025

Miramar, fla., jan. 15, 2025 (globe newswire) -- hcw biologics inc. (“hcwb” or “hcw biologics”), (nasdaq: hcwb), a u.s.-based clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between chronic inflammation and disease, announced today that hing c.
HCWB Ratings Summary
HCWB Quant Ranking